{
  "Variants Include": [
    {
      "Gene": "TERT",
      "variants": [
        {
          "HGVS": "NM_003291.3:c.2316C>T",
          "cDNA Change": {
            "transcript": "NM_003291.3",
            "ref": "C",
            "alt": "T",
            "position": "2316"
          },
          "Protein Change": {
            "ref": "T",
            "alt": "M",
            "position": "772"
          },
          "Description in input context": "c.2316C>T (p.T772M) in the TERT gene, a missense mutation in the catalytic domain leading to reduced telomerase activity."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Dyskeratosis Congenita",
    "MONDO": "MONDO:0006707"
  },
  "Experiment Method": [
    {
      "Assay Method": "Telomere Length Analysis",
      "Material used": {
        "Material Source": "Patient-derived fibroblasts",
        "Material Name": "Fibroblasts from patients with TERT c.2316C>T and control fibroblasts",
        "Description": "Telomere length was measured in fibroblasts from patients with the TERT c.2316C>T mutation and control fibroblasts."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_003291.3:c.2316C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced telomerase activity",
          "Result Description": "Patients with the TERT c.2316C>T mutation exhibited significantly shorter telomeres compared to control fibroblasts."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each group."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Control fibroblasts from unaffected individuals were used as positive controls."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Fibroblasts with no TERT mutations were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used to compare telomere lengths between groups."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Telomere length within 1 standard deviation of control samples.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Telomere length reduced by ≥20% compared to control samples.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunoblotting for TERT",
      "Material used": {
        "Material Source": "Patient-derived fibroblasts",
        "Material Name": "Fibroblasts from patients with TERT c.2316C>T and control fibroblasts",
        "Description": "TERT protein levels were assessed in fibroblasts from patients and controls."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_003291.3:c.2316C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced TERT expression",
          "Result Description": "Western blot analysis showed decreased TERT protein levels in patients with the TERT c.2316C>T mutation."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each group."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Control fibroblasts were used as positive controls for TERT expression."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Fibroblasts with no TERT mutations were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used to compare TERT expression levels between groups."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "TERT expression ≥80% of control levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "TERT expression <50% of control levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Functional Assay for Telomerase Activity",
      "Material used": {
        "Material Source": "Patient-derived fibroblasts",
        "Material Name": "Fibroblasts from patients with TERT c.2316C>T and control fibroblasts",
        "Description": "Telomerase activity was measured in fibroblasts from patients and controls."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_003291.3:c.2316C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced telomerase activity",
          "Result Description": "Telomerase activity was significantly lower in patients with the TERT c.2316C>T mutation compared to controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each group."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Control fibroblasts were used as positive controls for telomerase activity."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Fibroblasts with no TERT mutations were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used to compare telomerase activity between groups."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Telomerase activity within 1 standard deviation of control samples.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Telomerase activity reduced by ≥30% compared to control samples.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}